Prelude Therapeutics Incorporated (PRLD) Q3 2025 Earnings Call Transcript
Source: SeekingAlpha
2025-11-12 20:31:32 ET
Prelude Therapeutics Incorporated (PRLD) Q3 2025 Earnings Call November 12, 2025 8:00 AM EST...
Read the full article on Seeking Alpha
For further details see:
Prelude Therapeutics Incorporated (PRLD) Q3 2025 Earnings Call Transcript
Prelude Therapeutics Incorporated
NASDAQ: PRLD
PRLD Trading
9.38% G/L:
$3.85 Last:
405,426 Volume:
$3.725 Open:
PRLD Latest News
March 10, 2026 07:01:00 am
Prelude Therapeutics Reports Full Year 2025 Financial Results and Provides Program Outlook for 2026
February 17, 2026 08:24:00 am
The FDA Cleared 50 Oncology Approvals in 2025 and the Pipeline Keeps Accelerating
PRLD Stock Data
$130,131,109
16,400,390
0.33%
16
N/A
Biotechnology & Life Sciences
Healthcare
US
Wilmington
